Ostrum Asset Management US’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-6,521
Closed -$1.27M 49
2018
Q4
$1.27M Buy
+6,521
New +$1.27M 0.19% 63

Other funds holding AMGN

Ostrum Asset Management US's AMGN Position: Q1 2019 in Review

Ostrum Asset Management US sold out of Amgen (AMGN) in Q1 2019, closing a stake of 6,521 shares — an estimated $1.27M sold.

Ostrum Asset Management US first reported a position in AMGN in Q4 2018 and held it in 1 quarter. The position peaked at $1.27M in Q4 2018. 1,887 funds tracked by Wall St. Rank hold AMGN as of Q1 2019.

  • Ostrum Asset Management US reported no remaining Amgen position as of Q1 2019 after selling out during the quarter.
  • Ostrum Asset Management US sold 6,521 Amgen shares in Q1 2019, an estimated $1.27M.
  • Ostrum Asset Management US first reported a position in Amgen in Q4 2018 and held it in 1 quarter.
  • Ostrum Asset Management US's Amgen position peaked at $1.27M in Q4 2018.
  • 1,887 funds tracked by Wall St. Rank held Amgen as of Q1 2019.

Based on Ostrum Asset Management US's 13F filing for Q1 2019, filed 15 May 2019.